Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it said Tuesday, in a move to expand access and ease supply constraints.
Add Yahoo as a preferred source to see more of our stories on Google. Drugmaker Eli Lilly is significantly lowering the prices of the two lowest doses of its blockbuster weight loss drug Zepbound, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results